Published in FEBS Lett on September 25, 1998
The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev (2006) 6.80
Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia (2010) 1.70
Altered white matter microstructure in adolescent substance users. Psychiatry Res (2009) 1.58
Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms. Hepatology (2015) 1.48
Recent advances in the understanding of the role of the endocannabinoid system in liver diseases. Dig Liver Dis (2010) 1.48
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. Br J Pharmacol (2003) 1.47
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism. Br J Pharmacol (2005) 1.23
The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase. Br J Pharmacol (2003) 1.22
The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas. PLoS One (2010) 1.21
CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents. Clin Immunol (2006) 1.20
The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt. Biochem J (2000) 1.19
The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway. Am J Physiol Gastrointest Liver Physiol (2008) 1.18
Cannabinoids and cancer: pros and cons of an antitumour strategy. Br J Pharmacol (2006) 1.18
CB(1) cannabinoid receptors and their associated proteins. Curr Med Chem (2010) 1.15
A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cells. Mol Cancer Ther (2011) 1.13
Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas--possible role of Cannabis inhalation. Childs Nerv Syst (2011) 1.13
De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis. Biochem J (2002) 1.13
Novel delivery strategies for glioblastoma. Cancer J (2012) 1.01
Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival. Mol Cancer Ther (2010) 1.00
Cannabis and tobacco smoke are not equally carcinogenic. Harm Reduct J (2005) 0.99
Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor. Lab Invest (2011) 0.96
Harm reduction--the cannabis paradox. Harm Reduct J (2005) 0.94
Tetrahydrocannabinol-induced neurotoxicity depends on CB1 receptor-mediated c-Jun N-terminal kinase activation in cultured cortical neurons. Br J Pharmacol (2003) 0.91
Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects. Front Behav Neurosci (2011) 0.91
The cannabinoid receptors are required for ultraviolet-induced inflammation and skin cancer development. Cancer Res (2008) 0.90
Cannabinoids attenuate cancer pain and proliferation in a mouse model. Neurosci Lett (2010) 0.88
Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling. Exp Cell Res (2010) 0.88
Ceramide sensitizes astrocytes to oxidative stress: protective role of cannabinoids. Biochem J (2004) 0.87
Changes in the endocannabinoid system may give insight into new and effective treatments for cancer. Vitam Horm (2009) 0.83
WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture. PLoS One (2015) 0.79
The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail. J Neurochem (2011) 0.79
A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis. Invest New Drugs (2009) 0.78
Dual neuroprotective and neurotoxic effects of cannabinoid drugs in vitro. Cell Mol Neurobiol (2010) 0.78
Endocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex. Br J Pharmacol (2010) 0.77
The endocannabinoid system and sex steroid hormone-dependent cancers. Int J Endocrinol (2013) 0.77
G protein-coupled receptors as oncogenic signals in glioma: emerging therapeutic avenues. Neuroscience (2014) 0.76
Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716). Naunyn Schmiedebergs Arch Pharmacol (2008) 0.76
Prolonged activation of human islet cannabinoid receptors in vitro induces adaptation but not dysfunction. BBA Clin (2016) 0.75
Molecular mechanisms involved in the antitumor activity of cannabinoids on gliomas: role for oxidative stress. Cancers (Basel) (2010) 0.75
Anti‑carcinogenic activity of anandamide on human glioma in vitro and in vivo. Mol Med Rep (2015) 0.75
Gαs signalling of the CB1 receptor and the influence of receptor number. Br J Pharmacol (2017) 0.75
Two kinds of insertions in bacterial genes. Mol Gen Genet (1972) 3.68
Regulation of repressor expression in lambda. Proc Natl Acad Sci U S A (1970) 3.12
Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med (2000) 2.85
Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem (2001) 2.30
IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet (2000) 2.12
Mapping and functional analysis of y and CII mutants. Mutat Res (1969) 1.86
Chemotactic signals induce cell differentiation in Dictyostelium discoideum. Proc Natl Acad Sci U S A (1975) 1.68
Socioeconomic factors associated with risk of upper aerodigestive tract cancer in Europe. Eur J Cancer (2009) 1.66
Mutations of coliphage lambda affecting the expression of replicative functions O and P. Mol Gen Genet (1970) 1.66
Follow up after spontaneous coronary artery dissection: a report of five cases. Heart (1996) 1.55
[Physiological relationship between the temperate phages lambda and phi80]. Mol Gen Genet (1970) 1.50
The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes. FEBS Lett (2001) 1.49
Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer Res (2001) 1.49
Skin and wound infection by rapidly growing mycobacteria: an unexpected complication of liposuction and liposculpture. The Venezuelan Collaborative Infectious and Tropical Diseases Study Group. Arch Dermatol (2000) 1.47
Isolation and characterization of new sus (amber) mutants of bacteriophage lambda. Mutat Res (1968) 1.45
Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat. Hepatology (2001) 1.43
Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am Heart J (2000) 1.41
1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Brain Res Mol Brain Res (1994) 1.32
Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. Cell Death Differ (2011) 1.32
The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK. Oncogene (2010) 1.32
Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells. FEBS Lett (1999) 1.27
A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer (2006) 1.24
Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism. Arch Biochem Biophys (1997) 1.24
The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt. Biochem J (2000) 1.19
Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1- phosphate and induces cell death. Proc Natl Acad Sci U S A (2000) 1.19
De novo-synthesized ceramide signals apoptosis in astrocytes via extracellular signal-regulated kinase. FASEB J (2000) 1.19
The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase. Mol Pharmacol (2000) 1.17
Stability and freeze-drying of cyclosporine loaded poly(D,L lactide-glycolide) carriers. Eur J Pharm Sci (1999) 1.13
1,25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. Neuroreport (1996) 1.13
The AMP-activated protein kinase is involved in the regulation of ketone body production by astrocytes. J Neurochem (1999) 1.13
1,25-dihydroxyvitamin D3 regulates the synthesis of gamma-glutamyl transpeptidase and glutathione levels in rat primary astrocytes. J Neurochem (1999) 1.13
Influence of physicians' life stances on attitudes to end-of-life decisions and actual end-of-life decision-making in six countries. J Med Ethics (2008) 1.12
Isolation and characterization of deletions in bacteriophage lambda residing as prophage in E. coli K 12. Mol Gen Genet (1972) 1.11
1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Brain Res Mol Brain Res (1997) 1.08
1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes. Neuroreport (1994) 1.07
[Detection of IgM against the dengue++ virus in whole blood absorbed on filter paper]. Rev Panam Salud Publica (1998) 1.05
Neuropsychological test scores, academic performance, and developmental disorders in Spanish-speaking children. Dev Neuropsychol (2001) 1.05
Expression of inducible nitric oxide synthase during rat brain inflammation: regulation by 1,25-dihydroxyvitamin D3. Glia (1998) 1.03
Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes. Mol Pharmacol (1998) 1.03
Control of the cell survival/death decision by cannabinoids. J Mol Med (Berl) (2001) 1.01
The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas. Oncogene (2012) 1.00
Evidence that the AMP-activated protein kinase stimulates rat liver carnitine palmitoyltransferase I by phosphorylating cytoskeletal components. FEBS Lett (1998) 1.00
Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. Eur J Pharm Biopharm (2000) 0.98
pdsA, a gene involved in the production of active phosphodiesterase during starvation of Dictyostelium discoideum amoebae. Mol Gen Genet (1980) 0.98
Lipopolysaccharide-stimulated rat brain macrophages release NGF in vitro. Dev Biol (1989) 0.97
Expression and functionality of the trkA proto-oncogene product/NGF receptor in undifferentiated hematopoietic cells. Blood (1994) 0.96
The role of phosphodiesterase in aggregation of Dictyostelium discoideum. J Cell Sci (1978) 0.95
Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action. Cell Death Differ (2011) 0.95
Rat oligodendrocytes express the vitamin D(3) receptor and respond to 1,25-dihydroxyvitamin D(3). Glia (2000) 0.95
Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate. J Androl (2001) 0.95
[Selection of mutants of lambda bacteriophage incapable of replicating]. C R Acad Sci Hebd Seances Acad Sci D (1971) 0.94
A separate phosphodiesterase for the hydrolysis of cyclic guanosine 3',5'-monophosphate in growing Dictyostelium discoideum amoebae. Eur J Biochem (1980) 0.93
Cyclosporine-loaded polycaprolactone nanoparticles: immunosuppression and nephrotoxicity in rats. Eur J Pharm Sci (2001) 0.93
1,25-Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis. J Neurosci Res (1991) 0.93
Ceramide: a new second messenger of cannabinoid action. Trends Pharmacol Sci (2001) 0.92
The CB(1) cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan. Mol Pharmacol (2001) 0.92
Regulation of peripherin in mouse neuroblastoma and rat PC 12 pheochromocytoma cell lines. Dev Neurosci (1985) 0.92
The effect of divalent cations on aggregation of Dictyostelium discoideum. Differentiation (1978) 0.91
Differentially expressed genes in C6.9 glioma cells during vitamin D-induced cell death program. Cell Death Differ (1998) 0.90
Personal exposure to particulate matter is associated with worse health perception in adult asthma. J Investig Allergol Clin Immunol (2011) 0.90
Studies on the intracellular localization of acetyl-CoA carboxylase. Biochem Biophys Res Commun (1997) 0.89
Role of carnitine palmitoyltransferase I in the control of ketogenesis in primary cultures of rat astrocytes. J Neurochem (1998) 0.89
Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): a clinical trial and an in vivo efficacy test in sheep. Vet Parasitol (2013) 0.88
Synthesis of 1,25-dihydroxyvitamin D3 by rat brain macrophages in vitro. J Neurosci Res (1994) 0.88
Development of a new cyclosporine formulation based on poly(caprolactone) microspheres. J Microencapsul (2002) 0.88
1,25-Dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro. J Neurosci Res (1998) 0.87
Differential regulation of GDNF, neurturin, and their receptors in primary cultures of rat glial cells. J Neurosci Res (2001) 0.87
Mortality, incidence of cardiovascular diseases, and educational level among the diabetic and non-diabetic populations in two large Italian cities. Diabetes Res Clin Pract (2011) 0.87
Intracerebral implantation of NGF-releasing biodegradable microspheres protects striatum against excitotoxic damage. Exp Neurol (2000) 0.86
Specificity of polarity suppression in E. coli: correction of defects in gene N, but not in gene Q, of phage lambda. Mol Gen Genet (1976) 0.86
Cyclic GMP and cyclic AMP changes in response to folic acid pulses during cell development of Dictyostelium discoideum. Cell Differ (1979) 0.85
Decreased plasma folate concentration in young and elderly healthy subjects after a short-term supplementation with isotretinoin. J Eur Acad Dermatol Venereol (2008) 0.83
Dictyostelium discoideum surface changes elicited by high concentrations of cAMP. Exp Cell Res (1979) 0.83
[Atherogenic lipid profile in children with subclinical hypothyroidism]. An Pediatr (Barc) (2005) 0.83
GABAergic drugs and conflict behavior in the rat: lack of similarities with the actions of benzodiazepines. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.83
[Concentrations of serum lipids in children with Down's syndrome]. Arch Biol Med Exp (Santiago) (1991) 0.83
1,25 Dihydroxyvitamin D3 exerts regional effects in the central nervous system during experimental allergic encephalomyelitis. J Neuropathol Exp Neurol (1996) 0.82
Different mechanisms mediate the rejection of porcine neurons and endothelial cells transplanted into the rat brain. Xenotransplantation (2001) 0.82
1,25-Dihydroxyvitamin D3 regulates the expression of the low-affinity neurotrophin receptor. Brain Res Mol Brain Res (1996) 0.82
Involvement of Ca2+/calmodulin-dependent protein kinase II in the activation of carnitine palmitoyltransferase I by okadaic acid in rat hepatocytes. Biochem J (1997) 0.82
[Backache in a 70-yr-old man]. Enferm Infecc Microbiol Clin (2000) 0.82
Enhancement of the synthesis and secretion of nerve growth factor in primary cultures of glial cells by proteases: a possible involvement of thrombin. J Neurochem (1993) 0.81
Malonyl-CoA-independent acute control of hepatic carnitine palmitoyltransferase I activity. Role of Ca2+/calmodulin-dependent protein kinase II and cytoskeletal components. J Biol Chem (1998) 0.81
The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme. J Neurochem (1999) 0.81
Dependency of cyclosporine tissue distribution and metabolism on the age and gender of rats after a single intravenous dose. Int J Pharm (2000) 0.80
Fortuitous detection of prosthetic valve endocarditis caused by an uncommon etiologic agent. J Thorac Cardiovasc Surg (1994) 0.80
Life course social mobility and risk of upper aerodigestive tract cancer in men. Eur J Epidemiol (2010) 0.80
1,25-Dihydroxyvitamin D3 induces programmed cell death in a rat glioma cell line. J Neurosci Res (1996) 0.80
Messenger RNAs of beta-amyloid precursor protein and prion protein are regulated by nerve growth factor in PC12 cells. Int J Dev Neurosci (1988) 0.80
Neuronal localization of the nerve growth factor precursor-like immunoreactivity in the rat brain. Int J Dev Neurosci (1990) 0.80
Role of medical history and medication use in the aetiology of upper aerodigestive tract cancers in Europe: the ARCAGE study. Ann Oncol (2011) 0.80